StratCell

STRAT-CELL seeks to facilitate clinical implementation of new strategies for gene-edited cytotoxic lymphocytes in cancer therapy at the Oslo University Hospital

[StratCell @StratCell]

Come to Norway and help us develop new TCR-T and CAR-NK cell strategies

[MalmbergLab @MalmbergLab]

Very exciting opportunity to lead a brand new Centre for Advanced Cell Therapy @Oslounivsykehus. Join us in the effort to translate new biological insights in NK cell and T cell biology into therapies that make a difference for patients with cancer.

[Mohamad Mohty @Mohty_EBMT]

New hope for a CAR-T cell construct in AML.
⁦@BloodJournal⁩

[Sadaf Shadan @sshadan]

A resource paper @nature reveals intracellular locations of over 4,000 proteins, and nearly 36,000 interactions between proteins -- including those at mitochondrion-ER interface. Online tools are available for mining the dataset https://t.co/KE4CHnBXpE

https://t.co/wNi1ZNg8Xr

[David R. Liu @davidrliu]

Today we report in @Nature a base editing strategy that efficiently corrects the mutation in the β-globin gene HBB that causes sickle cell disease (SCD), the most common deadly genetic disorder, rescuing the disease in mice. https://t.co/Gj8VOAFrc1
https://t.co/gzO3WwNuKT
1/11

[StratCell @StratCell]

Join us this Thursday-Friday at the @JInternMed Symposium “Precision Medicine in Hematology”. Cell therapy strategies discussed by @JOlweus and @MalmbergLab.

[Jordan Gauthier @drjgauthier]

First description of two cases of malignant lymphoma derived from piggyBac CD19 CAR T cells.
Not all gene editing methods are equal! https://t.co/cOuJ26QTVm @BloodJournal

[StratCell @StratCell]

This is absolutely fantastic! Let the fun begin! New therapies based on #NKcells #Tcells #TCR #CAR and more..

[Kjetil Tasken @KjetilTasken]

At @Oslounivsykehus we are very happy for the ACT-centre, established through a 50-mNOK donation from S.&.A.Musts Fund @Kreftforeningen and @radforsk to make new clinical cell-gene therapy products! See Søndagsrevyen @NRKno and here:
https://t.co/Tk50xqeKOD
@JOlweus @MalmbergLab

[Mjösberg Lab @MjosbergL]

Interested in studying ILCs or working with single-cell sequencing in an ERC-funded postdoc? We are looking for an ambitious postdoc to join our talented team of immunologists! Deadline for applications is March 31st. For more information: https://t.co/mno2fhzQTe

[StratCell @StratCell]

So many friends on this list!

[Nicholas Huntington @Dr_Nick_Bikes]

Nice list!!. @oNKo_innate landed P2. Front row of the grid 🙌 Drag race to the first corner 😉 Some of these innovative crew are going to crack the NK puzzle and thousands of cancer patients world will benefit 👊👊👊

[Saheli Sadanand @SaheliSadanand]

A bench-to-bedside CD19 #CARTcells design + clinical trial study from @sghorashian, morning session speaker Martin Pule, Persis Amrolia and colleagues @ucl #VKSSmartCells21 #NMEDClinical https://t.co/RhqNK7kkMq

[Saheli Sadanand @SaheliSadanand]

Excited that this is now live on @NatureMedicine! Promising #Tcell #immunotherapy results in patients with #HPV-associated metastatic epithelial cancers 👉https://t.co/FtUKva80GT
#cervicalcancer #HNSCC @NCIResearchCtr @nciccr_gmb @CSHinrichsMD

[StratCell @StratCell]

T cell recognition of translational mistakes. Nice contribution by @JOlweus and team. Exciting new targets for TCR-T and TCR-NK cells @StratCell

[Fridtjof Lund-Johansen @F_Lund_Johansen]

An entirely new class of neoantigens, not detected at the DNA level. Congratulations to @JOlweus and her team for showing that peptides altered by translational mistakes are immunogenic!
https://t.co/9XIYggpPeP

[StratCell @StratCell]

Insights into the biology of repeated CAR T-cell infusions

[Jordan Gauthier @drjgauthier]

Our new paper on second infusions of CD19 CAR T-cells is finally out *in print* in @BloodJournal !
https://t.co/Ez9ozIaQvz
Time for a little Tweetorial 😄
Please retweet for your CAR T-cell friends/aficionados 😉
[THREAD 🧵] 1/24
@fredhutch @RyanCassaday

[StratCell @StratCell]

Strategic research program in cell therapy @StratCell Norway. Stay tuned for updates on our research on genetically engineered T and NK cells. https://t.co/ToB64DhM6R